Abbott Laboratories' High-Sensitive Troponin-I blood test was the first to be given a CE mark in Europe last fall for the prediction of heart disease risk when used alongside other assessments. Now, a prospective, epidemiologic U.S. study has shown that the test can be used to identify adults at risk of a cardiac event even independent of other heart disease risk factors. Read More
